Private Advisor Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,145
| Closed | -$761K | – | 2101 |
|
|
2021
Q2 | $761K | Buy |
4,145
+1,486
| +56% | +$273K | 0.01% | 1200 |
|
|
2021
Q1 | $406K | Buy |
2,659
+228
| +9% | +$34.8K | ﹤0.01% | 1406 |
|
|
2020
Q4 | $380K | Buy |
+2,431
| New | +$380K | ﹤0.01% | 1353 |
|
|
2020
Q3 | – | Sell |
-890
| Closed | -$100K | – | 3829 |
|
|
2020
Q2 | $100K | Sell |
890
-1,558
| -64% | -$175K | ﹤0.01% | 1716 |
|
|
2020
Q1 | $220K | Buy |
+2,448
| New | +$220K | ﹤0.01% | 1198 |
|
|
2019
Q2 | – | Sell |
-3,066
| Closed | -$414K | – | 1747 |
|
|
2019
Q1 | $414K | Sell |
3,066
-536
| -15% | -$72.4K | 0.01% | 1049 |
|
|
2018
Q4 | $347K | Sell |
3,602
-250
| -6% | -$24.1K | 0.01% | 970 |
|
|
2018
Q3 | $535K | Sell |
3,852
-7,022
| -65% | -$975K | 0.01% | 957 |
|
|
2018
Q2 | $1.35M | Buy |
10,874
+8,536
| +365% | +$1.06M | 0.02% | 387 |
|
|
2018
Q1 | $260K | Sell |
2,338
-645
| -22% | -$71.7K | 0.01% | 951 |
|
|
2017
Q4 | $357K | Sell |
2,983
-180
| -6% | -$21.5K | 0.02% | 820 |
|
|
2017
Q3 | $446K | Buy |
3,163
+660
| +26% | +$93.1K | 0.01% | 945 |
|
|
2017
Q2 | $309K | Sell |
2,503
-6,451
| -72% | -$796K | 0.01% | 1060 |
|
|
2017
Q1 | $281K | Buy |
8,954
+7,224
| +418% | +$227K | 0.01% | 1108 |
|
|
2016
Q4 | $231K | Buy |
+1,730
| New | +$231K | 0.01% | 1081 |
|
|
2016
Q1 | – | Sell |
-2,394
| Closed | -$457K | – | 1158 |
|
|
2015
Q4 | $457K | Buy |
+2,394
| New | +$457K | 0.02% | 623 |
|
|
2015
Q1 | – | Sell |
-2,235
| Closed | -$414K | – | 1068 |
|
|
2014
Q4 | $414K | Buy |
+2,235
| New | +$414K | 0.03% | 608 |
|
|
2014
Q2 | – | Sell |
-2,541
| Closed | -$387K | – | 943 |
|
|
2014
Q1 | $387K | Buy |
+2,541
| New | +$387K | 0.04% | 489 |
|